miR-375 suppresses IGF1R expression and contributes to inhibition of cell progression in laryngeal squamous cell carcinoma

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Luo, Jie ^a   Wu, Jianhui ^a   Li, Zenghong ^b   Qin, Hao ^c   Wang, Bin ^a   Wong, Thian Sze ^b   Yang, Weiqiang ^a   Fu, Qing Ling ^a   Lei, Wenbin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c THE FIRST PEOPLE S HOSPITAL OF FOSHAN   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 375; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR; IGF1 PROTEIN, HUMAN; IGF1R PROTEIN, HUMAN; MICRORNA; MIRN375 MICRORNA, HUMAN; ONCOPROTEIN; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LARYNGEAL CANCER CELL LINE; LARYNX SQUAMOUS CELL CARCINOMA; LUCIFERASE ASSAY; MTT ASSAY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WILD TYPE; BIOSYNTHESIS; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETICS; LARYNX TUMOR; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LARYNGEAL NEOPLASMS; MICRORNAS; ONCOGENE PROTEIN V-AKT; RECEPTORS, SOMATOMEDIN; SIGNAL TRANSDUCTION;

EID: 84907504237     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/374598     Document Type: Article

References (33)

1. Z. Yang, Q. Meng, J. Luo et al., "Development and validation of the simplified Chinese version of EORTC QLQ-H&N35 for patients with head and neck cancer," Supportive Care in Cancer, vol. 20, no. 7, pp. 1555-1564, 2012.
2. E. Rudolph, G. Dyckhoff, H. Becher, A. Dietz, and H. Ramroth, "Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis," European Archives of Oto-Rhino-Laryngology, vol. 268, no. 2, pp. 165-179, 2011.
3. J. Ren, D. Zhu, M. Liu, Y. Sun, and L. Tian, "Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma," European Journal of Cancer, vol. 46, no. 18, pp. 3409-3416, 2010.
4. J. Fang, Z.Yu, M. Lian et al., "Knockdown of zinc finger protein, X-linked (ZFX) inhibits cell proliferation and induces apoptosis in human laryngeal squamous cell carcinoma," Molecular and Cellular Biochemistry, vol. 360, no. 1-2, pp. 301-307, 2012.
5. Z. Guan, X. R. Wang, M. F. Zhu et al., "Aurora-A, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells," Cancer Research, vol. 67, no. 21, pp. 10436-10444, 2007.
6. H. Chen, L. Zhou, G. Wan, T. Dou, and J. Tian, "BMI1 promotes the progression of laryngeal squamous cell carcinoma," Oral Oncology, vol. 47, no. 6, pp. 472-481, 2011.
7. B. Lu, W. Di, H. Wang, H. Ma, J. Li, and Q. Zhang, "Tumor suppressor TSLC1 is implicated in cell proliferation, invasion and apoptosis in laryngeal squamous cell carcinoma by regulating Akt signaling pathway," Tumor Biology, vol. 33, no. 6, pp. 2007-2017, 2012.
8. J. I. A. Tao, L. E. I. Wen-bin, S.U. Zhen-zhong, Z. H. U. Xiao-lin, W. E. N. Wei-ping, and L. Bing, "Expression and significance of AKT/mTOR signal pathway in laryngeal cancer," Journal of Sun Yat-sen University Medical Sciences, vol. 30, no. 1, p. 35, 2009.
9. J. A. Knowles, B. Golden, L. Yan, W. R. Carroll, E. E. Helman, and E. L. Rosenthal, "Disruption of the AKT pathway inhibits metastasis in an orthotopic model of head and neck squamous cell carcinoma," The Laryngoscope, vol. 121, no. 11, pp. 2359-2365, 2011.
10. J. M. Garcia Pedrero, D. Garcia Carracedo, C. Muñoz Pinto et al., "Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma," International Journal of Cancer, vol. 114, no. 2, pp. 242-248, 2005.
11. M. V. Iorio and C. M. Croce, "MicroRNAs in cancer: small molecules with a huge impact," Journal of Clinical Oncology, vol. 27, no. 34, pp. 5848-5856, 2009.
12. A. Krek, D. Grun, M. N. Poy et al., "Combinatorial microRNA target predictions," Nature Genetics, vol. 37, no. 5, pp. 495-500, 2005.
13. G. A. Calin, C. D. Dumitru, M. Shimizu et al., "Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia," Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 24, pp. 15524-15529, 2002.
14. A. B. Y. Hui, M. Lenarduzzi, T. Krushel et al., "Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas," Clinical Cancer Research, vol. 16,no. 4, pp. 1129-1139, 2010.
15. N. Rosenfeld, R. Aharonov, E. Meiri et al., "MicroRNAs accurately identify cancer tissue origin," Nature Biotechnology, vol. 26, no. 4, pp. 462-469, 2008.
16. F. Wang, G. Song, M. Liu, X. Li, and H. Tang, "MiRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line," FEBS Letters, vol. 585, no. 20, pp. 3263-3269, 2011.
17. X. Li, H. Wang, X. Peng, H. Zhou, and X. Wang, "MiR-1297 mediates PTEN expression and contributes to cell progression in LSCC," Biochemical and Biophysical Research Communications, vol. 427, no. 2, pp. 254-260, 2012.
18. O. Tetsu and F. McCormick, "β-catenin regulates expression of cyclin D1 in colon carcinoma cells," Nature, vol. 398, no. 6726, pp. 422-426, 1999.
19. R. Fang, T. Xiao, Z. Fang et al., "MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene," Journal of Biological Chemistry, vol. 287, no. 27, pp. 23227-23235, 2012.
20. J. K.Kim, J. H.Noh, K. H. Jung et al., "Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b," Hepatology, vol. 57, no. 3, pp. 1055-1067, 2013.
21. L. Mulrane, S. F. McGee, W. M. Gallagher, and D. P. O'Connor, "miRNA dysregulation in breast cancer," Cancer Research, vol. 73, no. 22, pp. 6554-6562, 2013.
22. M. N. Poy, L. Eliasson, J. Krutzfeldt et al., "A pancreatic islet-specific microRNA regulates insulin secretion," Nature, vol. 432, no. 7014, pp. 226-230, 2004.
23. X. He, Y. Chang, F. Meng et al., "MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo," Oncogene, vol. 31, no. 28, pp. 3357-3369, 2012.
24. K. L. Kong, D. L. W. Kwong, T. H. Chan et al., "MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor," Gut, vol. 61, no. 1, pp. 33-42, 2012.
25. C. B. Lajer, F. C. Nielsen, L. Friis-Hansen et al., "Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study," British Journal of Cancer, vol. 104, no. 5, pp. 830-840, 2011.
26. T. Harris, L. Jimenez, N. Kawachi et al., "Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas," The American Journal of Pathology, vol. 180, no. 3, pp. 917-928, 2012.
27. A.Hu and X. Jin, "Expression of mir-21 and mir-375 in laryngeal squamous cell carcinoma," Journal of Clinical Otorhinolaryngology Head and Neck Surgery, vol. 26, no. 18, pp. 788-792, 2012.
28. G. O. Hellawell, G. D. H. Turner, D. R. Davies, R. Poulsom, S. F. Brewster, and V.M. Macaulay, "Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease," Cancer Research, vol. 62, no. 10, pp. 2942-2950, 2002.
29. G. Furstenberger and H. J. Senn, "Insulin-like growth factors and cancer," The Lancet Oncology, vol. 3, no. 5, pp. 298-302, 2002.
30. M.M. Chitnis, J. S. P. Yuen, A. S. Protheroe, M. Pollak, and V. M. Macaulay, "The type 1 insulin-like growth factor receptor pathway," Clinical Cancer Research, vol. 14, no. 20, pp. 6364-6370, 2008.
31. G. Mountzios, I. Kostopoulos, V. Kotoula et al., "Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer," PLoS ONE, vol. 8, no. 1, Article ID e54048, 2013.
32. M. Molina-Arcas, D. C. Hancock, C. Sheridan, M. S. Kumar, and J. Downward, "Coordinate direct input of both KRAS and IGF1 receptor to activation of PI3 kinase in KRAS -mutant lung cancer," Cancer Discovery, vol. 3, no. 5, pp. 548-563, 2013.
33. A. Gallardo, E. Lerma, D. Escuin et al., "Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas," British Journal of Cancer, vol. 106, no. 8, pp. 1367-1373, 2012.